135 related articles for article (PubMed ID: 27571944)
1. Willingness to accept chemotherapy and attitudes towards costs of cancer treatment; A multisite survey study in the Netherlands.
van Dijk EF; Coşkuntürk M; Zuur AT; van der Palen J; van der Graaf WT; Timmer-Bonte JN; Wymenga AN
Neth J Med; 2016 Aug; 74(7):292-300. PubMed ID: 27571944
[TBL] [Abstract][Full Text] [Related]
2. [Attitudes to treatment with cytostatic agents. Do cancer patients, physicians, nurses and healthy individuals vary in their views?].
Bremnes RM; Wist EA; Andersen K
Tidsskr Nor Laegeforen; 1996 Sep; 116(21):2583-7. PubMed ID: 8928131
[TBL] [Abstract][Full Text] [Related]
3. Attitudes to chemotherapy: comparing views of patients with cancer with those of doctors, nurses, and general public.
Slevin ML; Stubbs L; Plant HJ; Wilson P; Gregory WM; Armes PJ; Downer SM
BMJ; 1990 Jun; 300(6737):1458-60. PubMed ID: 2379006
[TBL] [Abstract][Full Text] [Related]
4. Cancer patients, doctors and nurses vary in their willingness to undertake cancer chemotherapy.
Bremnes RM; Andersen K; Wist EA
Eur J Cancer; 1995 Nov; 31A(12):1955-9. PubMed ID: 8562147
[TBL] [Abstract][Full Text] [Related]
5. Experience with and attitudes to chemotherapy among newly employed nurses in oncological and surgical departments: a longitudinal study.
Bremnes RM
Support Care Cancer; 1999 Jan; 7(1):11-6. PubMed ID: 9926968
[TBL] [Abstract][Full Text] [Related]
6. Are older French patients as willing as older American patients to undertake chemotherapy?
Extermann M; Albrand G; Chen H; Zanetta S; Schonwetter R; Zulian GB; Cantor A; Droz JP
J Clin Oncol; 2003 Sep; 21(17):3214-9. PubMed ID: 12874269
[TBL] [Abstract][Full Text] [Related]
7. Patient willingness to undergo chemotherapy and thoracic radiotherapy for locally advanced non-small cell lung cancer.
Hirose T; Yamaoka T; Ohnishi T; Sugiyama T; Kusumoto S; Shirai T; Okuda K; Ohmori T; Adachi M
Psychooncology; 2009 May; 18(5):483-9. PubMed ID: 18942662
[TBL] [Abstract][Full Text] [Related]
8. Patients preferences in chemotherapy for advanced non-small-cell lung cancer.
Hirose T; Horichi N; Ohmori T; Kusumoto S; Sugiyama T; Shirai T; Ozawa T; Ohnishi T; Adachi M
Intern Med; 2005 Feb; 44(2):107-13. PubMed ID: 15750269
[TBL] [Abstract][Full Text] [Related]
9. High dose chemotherapy and hematopoietic stem cell transplantation: a study of treatment preference in patients with rheumatoid arthritis and rheumatologists.
Verburg RJ; Mahabali SD; Stiggelbout AM; Sont JK; van Laar JM
J Rheumatol; 2002 Aug; 29(8):1653-8. PubMed ID: 12180724
[TBL] [Abstract][Full Text] [Related]
10. Differences in attitude toward adjuvant chemotherapy between colorectal cancer survivors and the medical staff of Japanese hospitals.
Narita Y; Taniguchi H; Komori K; Kimura K; Kinoshita T; Komori A; Nomura M; Kadowaki S; Takahari D; Ura T; Andoh M; Muro K
Int J Clin Oncol; 2015 Aug; 20(4):755-60. PubMed ID: 25424249
[TBL] [Abstract][Full Text] [Related]
11. Women's willingness to accept perceived risks for vasomotor symptom relief.
Johnson FR; Ozdemir S; Hauber B; Kauf TL
J Womens Health (Larchmt); 2007 Sep; 16(7):1028-40. PubMed ID: 17903080
[TBL] [Abstract][Full Text] [Related]
12. Who wants second-line, palliative chemotherapy?
Balmer CE; Thomas P; Osborne RJ
Psychooncology; 2001; 10(5):410-8. PubMed ID: 11536419
[TBL] [Abstract][Full Text] [Related]
13. Shared decision-making in breast cancer: discrepancy between the treatment efficacy required by patients and by physicians.
Thiel FC; Schrauder MG; Fasching PA; Löhberg CR; Bani MR; Häberle L; Tänzer T; Radosavac D; Scharl A; Bauerfeind I; Gesslein J; Schulte H; Overbeck-Schulte B; Beckmann MW; Lux MP
Breast Cancer Res Treat; 2012 Oct; 135(3):811-20. PubMed ID: 22933029
[TBL] [Abstract][Full Text] [Related]
14. Palliative chemotherapy preferences and factors that influence patient choice in incurable advanced cancer.
Kim MK; Lee JL; Hyun MS; Do YR; Song HS; Kim JG; Bae SH; Ryoo HM; Park KU; Lee KH
Jpn J Clin Oncol; 2008 Jan; 38(1):64-70. PubMed ID: 18238880
[TBL] [Abstract][Full Text] [Related]
15. Survey of willingness to accept chemotherapy among elderly Malaysian patients.
Razali RM; Bee PC; Gan GG
Asian Pac J Cancer Prev; 2013; 14(3):2029-32. PubMed ID: 23679313
[TBL] [Abstract][Full Text] [Related]
16. Willingness to pay for new chemotherapy for advanced ovarian cancer.
Morris J; Perez D
N Z Med J; 2000 Apr; 113(1108):143-6. PubMed ID: 10872435
[TBL] [Abstract][Full Text] [Related]
17. Patients' preferences for adjuvant chemotherapy in early-stage breast cancer: is treatment worthwhile?
Jansen SJ; Kievit J; Nooij MA; de Haes JC; Overpelt IM; van Slooten H; Maartense E; Stiggelbout AM
Br J Cancer; 2001 Jun; 84(12):1577-85. PubMed ID: 11401308
[TBL] [Abstract][Full Text] [Related]
18. Medical oncologists' views on communicating with patients about chemotherapy costs: a pilot survey.
Schrag D; Hanger M
J Clin Oncol; 2007 Jan; 25(2):233-7. PubMed ID: 17210946
[TBL] [Abstract][Full Text] [Related]
19. Ethical problems in intensive care unit admission and discharge decisions: a qualitative study among physicians and nurses in the Netherlands.
Oerlemans AJ; van Sluisveld N; van Leeuwen ES; Wollersheim H; Dekkers WJ; Zegers M
BMC Med Ethics; 2015 Feb; 16():9. PubMed ID: 25880418
[TBL] [Abstract][Full Text] [Related]
20. Do oncologists believe new cancer drugs offer good value?
Nadler E; Eckert B; Neumann PJ
Oncologist; 2006 Feb; 11(2):90-5. PubMed ID: 16476830
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
